Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Samuel Weissman won second place at the 2019 Regeneron Science Talent Search. Next, he wants to help cure HIV.
“The Düsseldorf Patient” has been off HIV meds only since November 2018, so it is much too early to determine whether he has been cured.
In a study of people with a low but detectable viral load despite adherence to treatment, infected cells were apparently cloning themselves.
WNYC discusses the latest HIV news, including the 2nd person in long-term HIV remission, proposed federal health care cuts, PrEP and U=U.
In a recent small trial, researchers have been unable to detect viable virus in the tissues of two monkeys that received the treatment.
Researchers think a more efficient means of modifying immune cells to resist the virus could yield a stronger effect.
Perhaps amfAR sums it up best: “We’re certainly hopeful.”
Many HIV cure trials take participants off antiretrovirals for a period in order to see how well the investigational treatment works.
HIV cure research has principally focused on latently infected CD4 cells as the backbone of the viral reservoir.
Experimental agent shrinks HIV reservoir, but fails to delay viral rebound.
Can photodynamic therapy eliminate the virus that causes cervical, anal and oral cancer?
The inability to precisely assess reservoir size has greatly hindered efforts to determine the effects of experimental cure therapies.
Researchers examined differences in the strength of a gene called nef.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
Our January/February cover guys—David Massey and Johnny Lester (aka David & Johnny)—are a serodiscordant couple.
An HIV immunotherapy method performs well in early safety trial.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.